The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients
Peter J1, Nelson DR. Liver Int. 2015 Jan;35 Suppl 1:65-70. doi: 10.1111/liv.12718.
Author information
1Department of Medicine, Division of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
Abstract
Over the past year, interferon (IFN) free dosing regimens have become available to treat chronic hepatitis C. Offering high rates of sustained virological response (SVR), short treatment and improved tolerability, IFN-free treatment now represents the paradigm for both treatment-naïve and -experienced patients. Patients with prior treatment failure, in particular those with cirrhosis, still represent some of the most difficult to treat, but the availability of multiple agents that can interrupt several steps of the HCV lifecycle affords providers and patients with options that can be combined and individually tailored to each patient's unique needs to obtain high rates of SVR.